Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5663779 | 0.98 | CYP2C19 (0.44) | CYP2C19BLMPOLBATMLMNA | |
| SCHEMBL17003713 | 0.86 | CYP2C19 (0.40) | CYP2C19BLMPOLBATMLMNA | |
| SCHEMBL11660704 | 0.84 | CYP2C19 (0.41) | CYP2C19BLMPOLBATMLMNA | |
| SCHEMBL25612571 | 0.82 | CYP2C19 (0.40) | CYP2C19BLMPOLBATMLMNA | |
| SCHEMBL16628637 | 0.79 | PTGS1 (0.30) | CYP2C19BLMLMNAPTGS1PDE4A | |
| SCHEMBL10640370 | 0.78 | CYP2C19 (0.44) | CYP2C19BLMPOLBATMLMNA | |
| SCHEMBL1404473 | 0.77 | LMNA (0.39) | CYP2C19BLMLMNAPTGS1PDE4A | |
| SCHEMBL18139809 | 0.76 | PTGS1 (0.31) | CYP2C19BLMLMNAPTGS1PDE4A | |
| SCHEMBL5404283 | 0.74 | CYP2C19 (0.41) | CYP2C19BLMPOLBATMLMNA | |
| Ammonia Solution, Strong SCHEMBL18141068 | 0.74 | PTGS1 (0.30) | CYP2C19BLMLMNAPTGS1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1694637-A4 | PROCESS FOR SYNTHESIZING DISULFIDES | BIONUMERIK PHARMACEUTICALS INC (US) | 2007-09-26 | — | — | EP | claimed |
| JP-2007514755-A | — | — | 2007-06-07 | — | — | JP | claimed |
| EP-1694637-A2 | PROCESS FOR SYNTHESIZING DISULFIDES | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2006-08-30 | — | — | EP | claimed |
| US-7053240-B2 | Process for synthesizing disulfides | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2006-05-30 | — | — | US | claimed |
| WO-2005058005-A2 | PROCESS FOR SYNTHESIZING DISULFIDES | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| US-20050137419-A1 | Process for synthesizing disulfides | BIONUMERIK PHARMACEUTICALS, INC. | 2005-06-23 | — | — | US | claimed |
| EP-1694637-A4 | PROCESS FOR SYNTHESIZING DISULFIDES | BIONUMERIK PHARMACEUTICALS INC (US) | 2007-09-26 | — | — | EP | disclosed |
| EP-1694637-A2 | PROCESS FOR SYNTHESIZING DISULFIDES | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2006-08-30 | — | — | EP | disclosed |
| US-7053240-B2 | Process for synthesizing disulfides | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2006-05-30 | — | — | US | disclosed |
| WO-2005058005-A2 | PROCESS FOR SYNTHESIZING DISULFIDES | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2005-06-30 | — | — | WO | disclosed |
| US-20050137419-A1 | Process for synthesizing disulfides | BIONUMERIK PHARMACEUTICALS, INC. | 2005-06-23 | — | — | US | disclosed |
| US-4322214-A | USING A SULFUR OR SULFURIZED VAT DYE IN AN ALKALINE BATH CONTAINING A MERCAPTO COMPOUND AND A SULFITE SALT; LEVELING | ASAHI CHEMICAL COMPANY LIMITED (JP) | 1982-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137419-A1 | Process for synthesizing disulfides | TST, CBS, STS | CYP2C19 1803/4885BLM 3136/4885POLB 3457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.